Rivulet Media Inc (fka RIVU)

[Crimsonmark]

Wouldn't this be the cause/reason/bi-cause that the FDA is possibly putting orphan drug status on the product and potentially pushing it through green lighting? Doesn't it make sense that, even though its a very rare disease, the potential for a cure is exciting to the FDA and stipulations will be made during testing since they may not meet the testing criteria based on amount of patients?